(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

DR. MERAL'S ELIXIR

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

DR. MERAL'S ELIXIR

ST13

US500000088977485

Class

3, 5

Filing

88977485

Registration

6097999

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

38

Latest update

07/08/2025

Trademark type

Word

Nice classes

3, 5

Filing date

12/06/2018

Registration date

07/07/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/07/2020

Last transaction

07/08/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

03/10/2020

First use in commerce

03/10/2020

Drawing code

4

Owner type

16

Owner location

FORT LAUDERDALE, FL

Examiner

STRUCK, ROBERT

Law office

L90

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

DR. MERAL'S ELIXIRS LLC
Novatemed Innoceuticals Inc.

Representatives

Scott D. Smiley THE CONCEPT LAW GROUP, P.A.

Technical classification

Nice Classes

Class 3Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 3

Non-medicated preparations all for the care of hair and scalp

Class 5

Dietary supplements

Publications

History of USPTO decisions and trademark events.

38 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

07/07/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

07/07/2020

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

06/02/2020

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

06/01/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/13/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/13/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/11/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/07/2020

GNRT

NON-FINAL ACTION E-MAILED

05/07/2020

CNRT

SU - NON-FINAL ACTION - WRITTEN

05/07/2020

SUPC

STATEMENT OF USE PROCESSING COMPLETE

04/16/2020

DPCC

DIVISIONAL PROCESSING COMPLETE

04/16/2020

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

04/14/2020

IUAF

USE AMENDMENT FILED

03/20/2020

DRRR

DIVISIONAL REQUEST RECEIVED

03/20/2020

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

03/20/2020

EISU

TEAS STATEMENT OF USE RECEIVED

03/20/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

01/24/2020

EX1G

SOU EXTENSION 1 GRANTED

01/22/2020

EXT1

SOU EXTENSION 1 FILED

01/22/2020

EEXT

SOU TEAS EXTENSION RECEIVED

01/22/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/29/2019

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

07/23/2019

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

05/29/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/28/2019

PUBO

PUBLISHED FOR OPPOSITION

05/28/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/08/2019

ALIE

ASSIGNED TO LIE

04/19/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/02/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/20/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/19/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/19/2019

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/14/2019

GNRT

NON-FINAL ACTION E-MAILED

03/14/2019

CNRT

NON-FINAL ACTION WRITTEN

03/14/2019

DOCK

ASSIGNED TO EXAMINER

03/06/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/27/2018

NWAP

NEW APPLICATION ENTERED

12/10/2018

Continuous trademark protection

Get notified about every new filing that threatens DR. MERAL'S ELIXIR or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.